Annual SG&A:
$0.00-$47.28M(-100.00%)Summary
- As of today, SPRY annual SG&A is $0.00, with the most recent change of -$47.28 million (-100.00%) on December 31, 2024.
- During the last 3 years, SPRY annual SG&A has fallen by -$4.69 million (-100.00%).
- SPRY annual SG&A is now -100.00% below its all-time high of $47.28 million, reached on December 31, 2023.
Performance
SPRY SG&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Quarterly SG&A:
$0.00-$54.31M(-100.00%)Summary
- As of today, SPRY quarterly SG&A is $0.00, with the most recent change of -$54.31 million (-100.00%) on September 30, 2025.
- Over the past year, SPRY quarterly SG&A has dropped by -$19.28 million (-100.00%).
- SPRY quarterly SG&A is now -100.00% below its all-time high of $54.31 million, reached on June 30, 2025.
Performance
SPRY Quarterly SG&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM SG&A:
-$735.96M-$80.04M(-12.20%)Summary
- As of today, SPRY TTM SG&A is -$735.96 million, with the most recent change of -$80.04 million (-12.20%) on September 30, 2025.
- Over the past year, SPRY TTM SG&A has dropped by -$778.96 million (-1811.33%).
- SPRY TTM SG&A is now -1053.77% below its all-time high of -$63.79 million.
Performance
SPRY TTM SG&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Selling, General & Administrative Expenses Formula
SG&A = Total Operating Expenses - Cost of Goods Sold - Research & Development
SPRY Selling, General & Administrative Expenses Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1Y1 Year | -100.0% | -100.0% | -1811.3% |
| 3Y3 Years | -100.0% | -100.0% | -4891.7% |
| 5Y5 Years | -100.0% | -100.0% | -10000.0% |
SPRY Selling, General & Administrative Expenses Highs & Lows
| PeriodPeriod | Annual vs HighAnnual vs High | Annual vs LowAnnual vs Low | Quarter. vs HighQuarter. vs High | Quarter. vs LowQuarter. vs Low | TTM vs HighTTM vs High | TTM vs LowTTM vs Low | |
|---|---|---|---|---|---|---|---|
| 3Y | 3-Year | -100.0% | at low | -100.0% | at low | -126.2% | +15.9% |
| 5Y | 5-Year | -100.0% | at low | -100.0% | at low | -660.8% | +15.9% |
| All-Time | All-Time | -100.0% | at low | -100.0% | at low | -1053.8% | +15.9% |
SPRY Selling, General & Administrative Expenses History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2025 | - | $0.00(-100.0%) | $130.91M(-12.8%) |
| Jun 2025 | - | $54.31M(+32.1%) | $150.19M(+43.3%) |
| Mar 2025 | - | $41.10M(+15.8%) | $104.82M(+46.2%) |
| Dec 2024 | $0.00(-100.0%) | $35.49M(+84.1%) | $71.67M(+66.7%) |
| Sep 2024 | - | $19.28M(+115.6%) | $43.01M(+11.1%) |
| Jun 2024 | - | $8.94M(+12.4%) | $38.70M(-10.1%) |
| Mar 2024 | - | $7.96M(+16.7%) | $43.06M(-8.9%) |
| Dec 2023 | $47.28M(+156.2%) | $6.82M(-54.4%) | $47.28M(+16.9%) |
| Sep 2023 | - | $14.98M(+12.6%) | $40.46M(+42.4%) |
| Jun 2023 | - | $13.30M(+9.2%) | $28.41M(+61.8%) |
| Mar 2023 | - | $12.18M(+316.3%) | $17.57M(+14.4%) |
| Dec 2022 | $18.46M | - | - |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2022 | - | $2.93M(+19.0%) | $15.36M(-21.1%) |
| Jun 2022 | - | $2.46M(+5.1%) | $19.47M(-18.1%) |
| Mar 2022 | - | $2.34M(-69.4%) | $23.78M(-15.3%) |
| Dec 2021 | $4.69M(-43.8%) | - | - |
| Dec 2021 | - | $7.64M(+8.5%) | $28.08M(+13.6%) |
| Sep 2021 | - | $7.04M(+4.1%) | $24.71M(+39.8%) |
| Jun 2021 | - | $6.76M(+1.7%) | $17.67M(+44.3%) |
| Mar 2021 | - | $6.65M(+55.9%) | $12.25M(+90.5%) |
| Dec 2020 | $8.34M(+225.6%) | $4.26M(+218.9%) | $6.43M(+127.7%) |
| Jun 2020 | - | $1.34M(+61.5%) | $2.82M(+90.0%) |
| Mar 2020 | - | $828.00K(+25.8%) | $1.49M(+125.8%) |
| Dec 2019 | $2.56M(-27.1%) | $658.00K | $658.00K |
| Dec 2018 | $3.52M | - | - |
FAQ
- What is ARS Pharmaceuticals, Inc. annual SG&A?
- What is the all-time high annual SG&A for ARS Pharmaceuticals, Inc.?
- What is ARS Pharmaceuticals, Inc. annual SG&A year-on-year change?
- What is ARS Pharmaceuticals, Inc. quarterly SG&A?
- What is the all-time high quarterly SG&A for ARS Pharmaceuticals, Inc.?
- What is ARS Pharmaceuticals, Inc. quarterly SG&A year-on-year change?
- What is ARS Pharmaceuticals, Inc. TTM SG&A?
- What is the all-time high TTM SG&A for ARS Pharmaceuticals, Inc.?
- What is ARS Pharmaceuticals, Inc. TTM SG&A year-on-year change?
What is ARS Pharmaceuticals, Inc. annual SG&A?
The current annual SG&A of SPRY is $0.00
What is the all-time high annual SG&A for ARS Pharmaceuticals, Inc.?
ARS Pharmaceuticals, Inc. all-time high annual SG&A is $47.28M
What is ARS Pharmaceuticals, Inc. annual SG&A year-on-year change?
Over the past year, SPRY annual SG&A has changed by -$47.28M (-100.00%)
What is ARS Pharmaceuticals, Inc. quarterly SG&A?
The current quarterly SG&A of SPRY is $0.00
What is the all-time high quarterly SG&A for ARS Pharmaceuticals, Inc.?
ARS Pharmaceuticals, Inc. all-time high quarterly SG&A is $54.31M
What is ARS Pharmaceuticals, Inc. quarterly SG&A year-on-year change?
Over the past year, SPRY quarterly SG&A has changed by -$19.28M (-100.00%)
What is ARS Pharmaceuticals, Inc. TTM SG&A?
The current TTM SG&A of SPRY is -$735.96M
What is the all-time high TTM SG&A for ARS Pharmaceuticals, Inc.?
ARS Pharmaceuticals, Inc. all-time high TTM SG&A is -$63.79M
What is ARS Pharmaceuticals, Inc. TTM SG&A year-on-year change?
Over the past year, SPRY TTM SG&A has changed by -$778.96M (-1811.33%)